Results 111 to 120 of about 83,065 (165)

c-abl is involved in the association of p53 and trk A

The p53 tumour suppressor phosphoprotein associates with proteins involved in DNA replication, transcription, cell cycle machinery and regulation of its own expression.
Brown A, Montano X, Browes C, Mitchell M
core  

<i>NTRK</i>-positive collision tumor of the gastrointestinal tract: a rare entity case report. [PDF]

Ann Med Surg (Lond)
Sirek A, Amann VC, Uzun S, Bubendorf L, Rosenberg R, Burri E, Häuptle P, Roma L, Mertz KD.   +8 more
europepmc   +1 more source

Delayed growth of SK-ES-1 Ewing sarcoma tumor xenografts is associated with reduced Trk and IGF1R pathway markers. [PDF]

Oncotarget
Dos Santos BA, Freire NXLH, Fratini L, Dalmolin M, Castro JM, Fernandes MAC, Gregianin L, Brunetto AXT, Brunetto AL, Rivero LFDR, Jaeger MDC, Roesler R, de Farias CB.   +12 more
europepmc   +1 more source

High-Grade Endometrial Stromal Sarcoma with <i>NTRK</i> Fusion and Response to Larotrectinib: A Case Report. [PDF]

J Clin Med
Bar-Noy T, Lozano-Franco R, Nagaria TS, Brodeur MN, Salvador S, Lau S.   +5 more
europepmc   +1 more source

A phase I study of TRK-950, an Anti-CAPRIN-1 antibody, as monotherapy and in combination with nivolumab in Japanese patients with advanced solid tumors. [PDF]

Invest New Drugs
Koyama T, Yonemori K, Sato J, Katsuya Y, Okada M, Yoshida T, Okano F, Yamamoto N.   +7 more
europepmc   +1 more source

The Potassium-Uptake Systems, Trk and Kdp, Coordinately Contribute to Growth Regulation and Survival of <i>M. tuberculosis</i> in Ion-Depleted and Acidic Environments. [PDF]

Int J Mol Sci
Osman AGE, Matjokotja MT, Allam M, Ismail A, Anderson R, Cholo MC.   +5 more
europepmc   +1 more source

ETV6-NTRK3 Fusion-Positive Late-Recurrent Parotid Carcinoma With Contralateral Axillary Metastasis and Early Response to Entrectinib: A Case Report. [PDF]

Cureus
Manea CA, Grigorean V, Serban D, Smarandache CG, Badiu DC.   +4 more
europepmc   +1 more source

Panel-negative strategy for suspected fusion-driven papillary thyroid carcinoma. [PDF]

Thyroid Res
Okubo Y, Takada I, Kadoya M, Toda S, Wada S, Masudo K, Miyagi Y, Hayashi H.   +7 more
europepmc   +1 more source

Regulatory Perspectives in Precision Oncology: Challenges and Opportunities for Tyrosine Receptor Kinase (NTRK) Inhibitors in Non-small Cell Lung Cancer (NSCLC). [PDF]

Cureus
Gainor J, Popat S, Bundy L.
europepmc   +1 more source

Detection of NTRK gene fusions in sarcomas: a comparative study of Pan-TRK immunohistochemistry, FISH, and RNA-Based NGS. [PDF]

Pathologica
Cocchi S, Gambarotti M, Gamberi G, Magagnoli G, Maioli M, Parra A, Sciulli E, Ibrahim T, Righi A, Benini S.   +9 more
europepmc   +1 more source